You are here

Rapid Cystic Fibrosis Mutation Screening Test

Award Information
Agency: Department of Health and Human Services
Branch: National Institutes of Health
Contract: 2R44HL074607-04A2
Agency Tracking Number: HL074607
Amount: $2,997,640.00
Phase: Phase II
Program: SBIR
Solicitation Topic Code: N/A
Solicitation Number: PHS2007-2
Timeline
Solicitation Year: 2008
Award Year: 2008
Award Start Date (Proposal Award Date): N/A
Award End Date (Contract End Date): N/A
Small Business Information
PHARMASEQ, INC. 11 DEER PARK DR, STE 104
MONMOUTH JUNCTION, NJ 08852
United States
DUNS: 027661870
HUBZone Owned: No
Woman Owned: No
Socially and Economically Disadvantaged: No
Principal Investigator
 WLODEK Mandecki
 (973) 972-4483
 W.MANDECKI@UMDNJ.EDU
Business Contact
 RICHARD MORRIS
Phone: (732) 355-0100
Email: mandecki@pharmaseq.com
Research Institution
N/A
Abstract

DESCRIPTION (provided by applicant): We propose to configure a DNA-based assay to detect mutations in the gene related to cystic fibrosis (CF), encoding the cystic fibrosis transmembrane conductance regulator protein (CFTR). The assay will have an extende

* Information listed above is at the time of submission. *

US Flag An Official Website of the United States Government